Myocardial Infarction Completed Phase 2 Trials for Sodium chloride (DB09153)

Also known as: Suspected myocardial infarction (MI) / Myocardial Infarct / MI / Myocardial Infarctions / Heart Attacks / Cardiac Infarct / Heart Attack / Myocardial Infarction (MI) / Cardiovascular Stroke / Stroke, Cardiovascular / Myocardial infarction (disorder) / Acute myocardial infarction / Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction / Attack heart (NOS) / Infarct myocardial / Right ventricular infarction / Attack coronary / Infarction of heart / Cardiac infarction, NOS / Attack - heart / Myocardial infarction, NOS / MI - myocardial infarction / Cardiac infarction / Heart attack, NOS / Infarction of heart, NOS / Myocardial infarction (& [acute]) or coronary thrombosis / Coronary artery thrombosis / Coronary artery thrombosis (disorder) / Thrombosis coronary / Coronary thrombosis / Occlusive coronary artery thrombus / Thrombosis - coronary / CT - Coronary thrombosis / (Myocardial infarction (& [acute] or [silent] or [cardiac rupture following])) or (coronary thrombosis)

IndicationStatusPhase
DBCOND0027900 (Myocardial Infarction)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01491074
Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Non-ST Elevation Myocardial InfarctionTreatment
NCT03004703
ASSessing the Effect of Anti-IL-6 Treatment in Myocardial Infarction: The ASSAIL-MI TrialTreatment